A nonradioactive multi-parameter flow cytometry assay was developed to identify antigen-specific lymphocytes in human subjects previously vaccinated against rabies virus and was subsequently compared to the standard tritiated thymidine method. A cell tracking dye, carboxyfluorescein succinimidyl ester, was used in combination with surface label for CD4 and CD8 cells in order to determine the response of lymphocytes to killed rabies virus in an antigen recall assay. The rabies virus-specific lymphocyte response was compared to the humoral immune response in each of ten vaccinated and five non-vaccinated subjects. Lymphocyte responses to rabies virus were observed in all ten vaccinated subjects; some noted as early as 3 days after stimulation while others were not until 7 days after stimulation. There was good agreement between the proliferation index of the CFSE assay and the simulation index of the [3H]thymidine assay (kappa statistic=0.73). An inverse relationship was detected between the level of rabies virus neutralizing antibody (RVNA) and the lymphocyte response to inactivated rabies virus in the vaccinated subjects. The association between cytokines production and level of humoral and cellular response was investigated in four representative subjects. Two vaccinated subjects with high proliferation indices and low RVNA titers produced Th1 type cytokines to rabies virus stimulation, whereas two vaccinated individuals with low proliferation indices and high RVNA titers responses did not produce these cytokines.
Similar content being viewed by others
REFERENCES
Haupt W: Rabies–Risk of exposure and current trends in prevention of human cases. Vaccine 17:1742–1749, 1999
Dietzschold B, Morimoto K, Hooper DC: Mechanisms of virus-induced neuronal damage and the clearance of viruses from the CNS. Curr Top Microbiol Immunol 253:145–155, 2001
Hooper DC, Sauder C, Scott GS, Dietzschold B, Richt JA: Immunopathology and immunoprotection in CNS virus infections: Mechanisms of virus clearance from the CNS. Curr Top Microbiol Immunol 265:163–182, 2002
Kuwert EK, Barsenbach J, Werner J, Marcus I, Scheiermann N, Grosse-Wilde H et al.: Early/high and late/low responders among HDCS vaccinees. In Cell Culture Rabies Vaccines and Their Protective Effect in Man, EK Kuwert, RJ Wiktor, H Koprowski (eds). Geneva, International Green Cross, 1981, pp 160–168
Strady C, Jaussaud R, Beguinot I, Lienard M, Strady A: Predictive factors for the neutralizing antibody response following pre-exposure rabies immunization: Validation of a new booster dose strategy. Vaccine 18:2661–2667, 2000
Aubert MF: Practical significance of rabies antibodies in cats and dogs. Rev Sci Tech 11:735–760, 1992
Hooper DC, Morimoto K, Bette M, Weihe E, Koprowski H, Dietzschold B: Collaboration of antibody and inflammation in clearance of rabies virus from the central nervous system. J Virol 72:3711–3719, 1998
Garenne M, Lafon M: Sexist diseases. Perspect Biol Med 41:176–189, 1998
Lafon M: Immunology. In Rabies, AC Jackson, WH Wunner (eds). San Diego, CA, Academic Press, 2002, pp 351–371
Hooper DC: The role of immune responses in the pathogenesis of rabies. J Neurovirol 11:88–92, 2005
Thraenhart O, Kreuzfelder E, Hillebrandt M, Marcus I, Ramakrishnan K, Fu ZF, et al.: Long-term humoral and cellular immunity after vaccination with cell culture rabies vaccines in man. Clin Immunol Immunopathol 71:287–292, 1994
Herzog M, Fritzell C, Lafage M, Montano Hirose JA, Scott-Algara D, Lafon M: T and B cell human responses to European bat lyssavirus after post-exposure rabies vaccination. Clin Exp Immunol 85:224–230, 1991
Fulcher D, Wong S: Carboxyfluorescein succinimidyl ester-based proliferative assays for assessment of T cell function in the diagnostic laboratory. Immunol Cell Biol 77:559–564, 1999
Givan AL, Fisher JL, Waugh M, Ernstoff MS, Wallace PK: A flow cytometric method to estimate the precursor frequencies of cells proliferating in response to specific antigens. J Immunol Methods 230:99–112, 1999
Smith JS, Yager PA, Baer GM: A rapid reproducible test for determining rabies neutralizing antibody. Bull World Health Organ 48:535–541, 1973
Habel K: Habel test for potency. In Laboratory Techniques in Rabies, FX Meslin, MM Kaplan, H Koprowski (eds). Geneva, World Health Organization, 1996, pp 369-373
Centers for Disease Control and Prevention: Recommendations of the Advisory Committee on Immunization Practices (ACIP). 48: 1–21. United States, Morbidity and Mortality Weekly Report, 1999
World Health Organization: World Health Organization Expert Committee on Rabies: Eighth Report. 824. Geneva, WHO Press, WHO Technical Report Series, 1992
Altman DG: Practical Statistics for Medical Research. London, Chapman and Hall, 1991
Esser MT, Marchese RD, Kierstead LS, Tussey LG, Wang F, Chirmule N et al.: Memory T cells and vaccines. Vaccine 21:419–430, 2003
Lafon M, Lafage M, Martinez-Arends A, Ramirez R, Vuillier F, Charron D et al.: Evidence for a viral superantigen in humans. Nature 358:507–510, 1992
Wells AD, Gudmundsdottir H, Turka LA: Following the fate of individual T cells throughout activation and clonal expansion. Signals from T cell receptor and CD28 differentially regulate the induction and duration of a proliferative response. J Clin Invest 100:3173–3183, 1997
Maino VC: Rapid assessment of antigen induced cytokine expression in memory T cells by flow cytometry. Vet Immunol Immunopathol 63:199–207, 1998
Lagrelius M, Jones P, Franck K, Gaines H: Cytokine detection by multiplex technology useful for assessing antigen specific cytokine profiles and kinetics in whole blood cultured up to seven days. Cytokine 33:156–165, 2006
ACKNOWLEDGMENTS
We would like to thank the rabies vaccinated and non-vaccinated individuals who participated in this study. We are indebted to Tammy Koopman and Mehrdad Ameri for their technical assistance and review of the manuscript and to Teri Ricke for her help with the RFFIT testing.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Moore, S.M., Wilkerson, M.J., Davis, R.D. et al. Detection of Cellular Immunity to Rabies Antigens in Human Vaccinees. J Clin Immunol 26, 533–545 (2006). https://doi.org/10.1007/s10875-006-9044-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10875-006-9044-0